This image shows first author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable genomic alterations directly from biopsy slides, making it significantly easier and cheaper to determine the best course of treatment for breast and ovarian cancers.